Notably, several researches indicate that MBX-8025 is capable to enhance insulin sensitivity, reverse dyslipidemia, mitigate hepatic accumulation of lipotoxic lipids, and ameliorate NASH pathology in diet-fed atherosclerotic obese diabetic mice in a mouse model of obesity, dyslipidemia and diabetes (27). This evidence concerns the gene INS and metabolic syndrome.